Edition:
United States

NxStage Medical Inc (NXTM.OQ)

NXTM.OQ on NASDAQ Stock Exchange Global Select Market

26.09USD
2:57pm EST
Change (% chg)

$0.20 (+0.77%)
Prev Close
$25.89
Open
$25.95
Day's High
$26.09
Day's Low
$25.60
Volume
118,322
Avg. Vol
282,011
52-wk High
$30.80
52-wk Low
$20.47

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Robert Funari

69 2014 Independent Chairman of the Board

Joseph Turk

49 2013 President

Jeffrey Burbank

54 2011 Chief Executive Officer, Director

Matthew Towse

54 2015 Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer

Robert Brown

58 2013 President of NxStage Kidney Care